1H-Pyrrolo[3,2-c]pyridine-6-carboxylic acid, 95.0%, 100mg

4-(3-Bromo-4-methylbenzyl)morpholine, 97%, 1g

(1R,5R)-3-methyl-3,6-diazabicyclo[3.2.0]heptane; bis(trifluoroacetic acid), 95.0%, 250mg

(R)-2-Amino-N-methyl-3-phenylpropanamide, 95.0%, 100mg

GC capillary column ROTI®Cap-5, 60 m, 0.32 mm, 0.35 µm, 1 Piece(s)

1-ethyl-2-piperidinecarboxylic acid hydrochloride, 95.0%, 1g

(2-(Benzyloxy)naphthalen-1-yl)boronic acid, 95.0%, 100mg

Dimethyl 2-aminomalonate hydrochloride, 95.0%, 25g

tert-Butyl 4-benzoylpiperidine-1-carboxylate, 95.0%, 25g

Methyl 2-((tert-butoxycarbonyl)amino)-3-nitrobenzoate, 95.0%, 1g

2-Methyl-7-azaspiro[3.5]nonan-2-ol hydrochloride, 95.0%, 10g

2-(4,6-Dimethylpyrimidin-2-yl)acetonitrile, 97%, 1g

(R)-2-((5-Chloro-4-iodopyridin-2-yl)amino)propan-1-ol, 95.0%, 250mg